Irhythm Technologies Stock News

iRhythm Technologies (IRTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Needham has upgraded iRhythm Technologies (IRTC) from hold to buy citing management commentary providing confidence on revenue growth.

IRTC earnings call for the period ending December 31, 2021.

SAN FRANCISCO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2021.

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 9.84% and 4.61%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and cardiac monitoring products, has seen a rise of 20% over the last one month (twenty-one tra

Citi analyst Joanne Wuensch raised the firm''s price target ((PT)) on iRhythm Technologies (IRTC) to $165 from $120 and keeps a Buy rating. The analyst believes updated reimbursement

iRhythm Technologies Inc (IRTC) shares closed this week 20.8% higher than it did at the end of last week. The stock is currently up 20.1% year-to-date, down 39.1% over the past 12 months, and up 353.4% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Shares traded as high as $144.45 and as low as $101.63 this week.Trading volume this week was 36.7% higher than the 10-day average and 80.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -3069.0% The company's stock price performance over the past 12 months lags the peer average by -658.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

After adding more than a quarter to its value on Monday, iRhythm Technologies <> continues to trade higher as the market weighs in on the updated reimbursement rates published

iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength

Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what''s behind that movement!

Reaching the highest level since April last year, iRhythm Technologies (IRTC) has added more than a quarter in value on above-average volume driven by speculation on Novitas rates,